Search filters

List of works by Elisabeth von Guggenberg

177Lu Labeled Cyclic Minigastrin Analogues with Therapeutic Activity in CCK2R Expressing Tumors: Preclinical Evaluation of a Kit Formulation.

scientific article

68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT

scientific article published on 01 April 2007

68Ga-PSMA-11 PET/CT in primary staging of prostate cancer: PSA and Gleason score predict the intensity of tracer accumulation in the primary tumour

scientific article

99mTc-EDDA/HYNIC-TOC and (18)F-FDG in thyroid cancer patients with negative (131)I whole-body scans.

scientific article published on 19 November 2003

99mTc-N4-[Tyr3]Octreotate Versus 99mTc-EDDA/HYNIC-[Tyr3]Octreotide: an intrapatient comparison of two novel Technetium-99m labeled tracers for somatostatin receptor scintigraphy.

scientific article

99mTc-labeling and in vitro and in vivo evaluation of HYNIC- and (Nalpha-His)acetic acid-modified [D-Glu1]-minigastrin.

scientific article published on July 2004

99mTc-labelled HYNIC-minigastrin with reduced kidney uptake for targeting of CCK-2 receptor-positive tumours

scientific article published on 17 February 2007

A fully automated synthesis for the preparation of 68Ga-labelled peptides.

scientific article published in November 2007

A novel CCK2/gastrin receptor-localizing radiolabeled peptide probe for personalized diagnosis and therapy of patients with progressive or metastatic medullary thyroid carcinoma: a multicenter phase I GRAN-T-MTC study

scientific article published on 05 December 2018

Albumin-based nanoparticles as magnetic resonance contrast agents: I. Concept, first syntheses and characterisation

scientific article published on 20 February 2010

Automated synthesis of an 18F-labelled pyridine-based alkylating agent for high yield oligonucleotide conjugation.

scientific article published on 19 April 2009

Cholecystokinin-2 Receptor Targeting with Novel C-terminally Stabilized HYNIC-Minigastrin Analogs Radiolabeled with Technetium-99m

article

Comparison of PEGylated and non-PEGylated proticles: An in vitro and in vivo study

scientific article published on 02 September 2019

Comparison of [68Ga]Ga-PSMA-11 PET/CT with [18F]NaF PET/CT in the evaluation of bone metastases in metastatic prostate cancer patients prior to radionuclide therapy

scientific article published on 16 May 2018

Comparison of different methods for radiochemical purity testing of [99mTc-EDDA-HYNIC-D-Phe1,Tyr3]-octreotide.

scientific article

Comparison of the binding and internalization properties of 12 DOTA-coupled and ¹¹¹In-labelled CCK2/gastrin receptor binding peptides: a collaborative project under COST Action BM0607.

scientific article published on 20 April 2011

Correction: Klingler, M., et al. Cholecystokinin-2 Receptor Targeting with Novel C-terminally Stabilized HYNIC-Minigastrin Analogs Radiolabeled with Technetium-99m. Pharmaceuticals 2019, 12, 13

scientific article published on 13 June 2019

Current knowledge on the sensitivity of the (68)Ga-somatostatin receptor positron emission tomography and the SUVmax reference range for management of pancreatic neuroendocrine tumours

scientific article

Cyclic minigastrin analogues for gastrin receptor scintigraphy with technetium-99m: preclinical evaluation.

scientific article published in August 2009

DOTA-MGS5, a New Cholecystokinin-2 Receptor-Targeting Peptide Analog with an Optimized Targeting Profile for Theranostic Use

scientific article published on 07 December 2018

Developing Targeted Hybrid Imaging Probes by Chelator Scaffolding

scientific article

Early PET imaging with [68]Ga-PSMA-11 increases the detection rate of local recurrence in prostate cancer patients with biochemical recurrence.

scientific article published on 6 June 2017

Early dynamic imaging in 68Ga- PSMA-11 PET/CT allows discrimination of urinary bladder activity and prostate cancer lesions

scientific article

Effect of N-Terminal Peptide Modifications on In Vitro and In Vivo Properties of 177Lu-Labeled Peptide Analogs Targeting CCK2R

scientific article published in 2023

Erratum: Site-specific stabilization of minigastrin analogs against enzymatic degradation for enhanced cholecystokinin-2 receptor targeting: Erratum

scientific article published on 19 June 2019

Exploiting the Concept of Multivalency with 68Ga- and 89Zr-Labelled Fusarinine C-Minigastrin Bioconjugates for Targeting CCK2R Expression.

scientific article published on 10 April 2018

In vitro characterization of two novel biodegradable vectors for the delivery of radiolabeled antisense oligonucleotides.

scientific article published on December 2010

Influence of PEGylation and RGD loading on the targeting properties of radiolabeled liposomal nanoparticles

scientific article

Influence of a novel, versatile bifunctional chelator on theranostic properties of a minigastrin analogue

scientific article

Influence of biological assay conditions on stability assessment of radiometal-labelled peptides exemplified using a 177Lu-DOTA-minigastrin derivative.

scientific article

Initial In Vitro and In Vivo Evaluation of a Novel CCK2R Targeting Peptide Analog Labeled with Lutetium-177

scientific article published on 08 October 2020

Intracellular signaling pathways regulating radioresistance of human prostate carcinoma cells.

scientific article published on November 2008

Methoxinine - an alternative stable amino acid substitute for oxidation-sensitive methionine in radiolabelled peptide conjugates

scientific article published on 5 January 2017

Multimerization results in formation of re-bindable metabolites: A proof of concept study with FSC-based minigastrin imaging probes targeting CCK2R expression

scientific article published in PLoS ONE

Multiparametric PET imaging in thyroid malignancy characterizing tumour heterogeneity: somatostatin receptors and glucose metabolism

scientific article published on 15 July 2015

Preclinical evaluation of radiolabeled DOTA-derivatized cyclic minigastrin analogs for targeting cholecystokinin receptor expressing malignancies.

scientific article published on June 2012

Preclinical pharmacokinetics, biodistribution, radiation dosimetry and toxicity studies required for regulatory approval of a phase I clinical trial with (111)In-CP04 in medullary thyroid carcinoma patients

scientific article published on 13 May 2016

Radiolabeling of lipid-based nanoparticles for diagnostics and therapeutic applications: a comparison using different radiometals

scientific article published in September 2010

Site-specific stabilization of minigastrin analogs against enzymatic degradation for enhanced cholecystokinin-2 receptor targeting.

scientific article published on 16 April 2018

Somatostatin receptor PET in neuroendocrine tumours: 68Ga-DOTA0,Tyr3-octreotide versus 68Ga-DOTA0-lanreotide ⬇️

scientific article published on November 14, 2012

Stabilization Strategies for Linear Minigastrin Analogues: Further Improvements via the Inclusion of Proline into the Peptide Sequence

scientific article published on 23 November 2020

Targeting properties of peptide-modified radiolabeled liposomal nanoparticles

scientific article published on 20 May 2011

Tumor targeting and imaging with dual-peptide conjugated multifunctional liposomal nanoparticles

scientific article published on 05 December 2013

[68Ga]NODAGA-RGD for imaging αvβ3 integrin expression.

scientific article published on 13 April 2011

Paulina is supported by:

About Paulina

Help